Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer with Different HER2 Expression Patterns

NCT06551220 · clinicaltrials.gov ↗

RECRUITING

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Trastuzumab Deruxtecan

Sponsor

Sun Yat-sen University